Fig. 3.
Expected percentage of pediatric indications which may benefit of MRgRT, based on numbers from the Dutch national cohort (2019) and divided into primary and metastatic tumor sites.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.